Non-transferrin-bound iron in myelodysplastic syndromes: a marker of ineffective erythropoiesis?

The Hematology Journal : the Official Journal of the European Haematology Association
A CortelezziMaria D Cappellini

Abstract

Iron overload is usually observed in patients (even untransfused) with myelodysplastic syndromes (MDS), and contributes towards the generation of low molecular weight iron complexes or non-transferrin-bound iron (NTBI), which in turn favors oxidative DNA damage and consequent apoptosis. Levels of NTBI and lipid peroxidation were evaluated by means of free serum malondyaldehyde (MDA) in untransfused MDS patients and we tried to correlate them with ineffective erythropoiesis, apoptosis and the pattern of in vitro growth. NTBI levels were found to be significantly higher in low-risk than in high-risk MDS patients, as well as in patients with a lower myeloid/erythroid ratio. MDA was found to be uniformly higher in the MDS patients as a whole than in normal controls. The bone marrow progenitor cells in the MDS patients with high NTBI levels showed a higher degree of apoptosis, but this difference was not statistically significant. Patients with a leukemic growth pattern had lower NTBI levels than those with a non-leukemic pattern. These data suggest that NTBI is related to the degree of ineffective erythropoiesis and that it contributes towards inducing apoptosis in MDS bone marrow precursors. The presence of leukemic growth is asso...Continue Reading

Citations

Sep 3, 2011·PloS One·Valeria SantiniMaria Domenica Cappellini
Oct 22, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Shucheng GuXiao Li
Feb 26, 2008·Leukemia & Lymphoma·Sameer MaheshAmit Verma
Sep 3, 2008·Bone Marrow Transplantation·V PullarkatS J Forman
Dec 24, 2011·International Journal of Hematology·Kazuki TaokaMineo Kurokawa
Jun 1, 2009·Expert Review of Hematology·Lisa Chodirker, Richard A Wells
Oct 13, 2010·Annals of Hematology·Norbert Gattermann, Eliezer A Rachmilewitz
May 31, 2003·International Journal of Hematology·Morag J Farquhar, David T Bowen
May 24, 2006·World Journal of Gastroenterology : WJG·Chun-Lian WangDong-Ye Yang
Feb 1, 2007·Current Hematologic Malignancy Reports·Peter-D Jensen
Oct 2, 2013·Indian Journal of Clinical Biochemistry : IJCB·Meghna Patel, D V S S Ramavataram
Apr 18, 2016·International Journal of Hematology·Satoshi ItoMikihiro Fujiya
Nov 14, 2008·American Journal of Hematology·Antonio PigaMaria Domenica Cappellini
May 23, 2020·Haematologica·Eva Hellström-LindbergPeter Greenberg
Mar 20, 2014·Expert Review of Anticancer Therapy·Drorit G Merkel, Arnon Nagler
Nov 23, 2019·Blood Reviews·Eolia BrissotMarie-Bérengère Troadec
Dec 5, 2020·Antioxidants·Alba Rodríguez-GarcíaMaría Linares
Jul 11, 2020·HemaSphere·Francesca VinchiUwe Platzbecker
Feb 2, 2010·Blood Reviews·Pierre Fenaux, Christian Rose
Aug 23, 2011·Biochimica Et Biophysica Acta·Pierre BrissotOlivier Loréal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Clinical Chemistry and Laboratory Medicine : CCLM
Marija Prezelj, Bojan Knap
Nederlands tijdschrift voor geneeskunde
Roderick P P W M MaasDorine W Swinkels
© 2022 Meta ULC. All rights reserved